Mechanisms of disease: pulmonary arterial hypertension
Top Cited Papers
- 21 June 2011
- journal article
- review article
- Published by Springer Nature in Nature Reviews Cardiology
- Vol. 8 (8) , 443-455
- https://doi.org/10.1038/nrcardio.2011.87
Abstract
Our understanding of, and approach to, pulmonary arterial hypertension has undergone a paradigm shift in the past decade. Once a condition thought to be dominated by increased vasoconstrictor tone and thrombosis, pulmonary arterial hypertension is now seen as a vasculopathy in which structural changes driven by excessive vascular cell growth and inflammation, with recruitment and infiltration of circulating cells, play a major role. Perturbations of a number of molecular mechanisms have been described, including pathways involving growth factors, cytokines, metabolic signaling, elastases, and proteases, that may underlie the pathogenesis of the disease. Elucidating their contribution to the pathophysiology of pulmonary arterial hypertension could offer new drug targets. The role of progenitor cells in vascular repair is also under active investigation. The right ventricular response to increased pressure load is recognized as critical to survival and the molecular mechanisms involved are attracting increasing interest. The challenge now is to integrate this new knowledge and explore how it can be used to categorize patients by molecular phenotype and tailor treatment more effectively.Keywords
This publication has 189 references indexed in Scilit:
- Mitochondrial metabolic adaptation in right ventricular hypertrophy and failureJournal of Molecular Medicine, 2010
- The effects of vasoactivity and hypoxic pulmonary hypertension on extralobar pulmonary artery biomechanicsJournal of Biomechanics, 2010
- The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricleJournal of Molecular Medicine, 2009
- Notch3 signaling promotes the development of pulmonary arterial hypertensionNature Medicine, 2009
- Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt–β-catenin and Wnt–RhoA–Rac1 pathwaysThe Journal of cell biology, 2009
- Vascular endothelial growth factor of the lung: friend or foeCurrent Opinion in Pharmacology, 2008
- Potassium channels in the regulation of pulmonary artery smooth muscle cell proliferation and apoptosis: pharmacotherapeutic implicationsBritish Journal of Pharmacology, 2008
- Alterations of cellular bioenergetics in pulmonary artery endothelial cellsProceedings of the National Academy of Sciences, 2007
- Classical transient receptor potential channel 6 (TRPC6) is essential for hypoxic pulmonary vasoconstriction and alveolar gas exchangeProceedings of the National Academy of Sciences, 2006
- Notch Signaling: Cell Fate Control and Signal Integration in DevelopmentScience, 1999